Refusal to waive IP rights for COVID-19 vaccines violates human rights: Experts
Sep 01, 2023, at 10:07 pm
UN rights experts called on States in the global North on Thursday to forgo intellectual property rights on COVID-19 vaccines and treatments in the name of human rights.
Johnson & Johnson Covid vaccine no longer available in US
May 16, 2023, at 09:56 pm
Los Angeles: Johnson & Johnson COVID-19 vaccine is no longer available in the United States, according to the U.S. Centers for Disease Control and Prevention (CDC).
Moderna sues Pfizer, BioNTech alleging patent infringement over Covid vaccine
Aug 27, 2022, at 02:38 am
Washington/IBNS: Moderna Friday announced to sue its suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their Covid-19 shot, which was administered to hundreds of millions around the world.
COVID-19: Covaxin, Corbevax get nod for 5-12 years
Apr 26, 2022, at 10:06 pm
New Delhi: Bharat Biotech's Covaxin has been approved for being administered to children between 6 and 12 years of age and Corbevax for children 5 to 12 years old, Union Health Minister Mansukh Mandaviya said on Wednesday.
COVID-19: Current vaccines may need to be updated, experts warn
Jan 12, 2022, at 06:59 pm
New York: Current COVID-19 vaccines may need to be updated to ensure their continued effectiveness against Omicron and future variants, an expert group appointed by the World Health Organization (WHO) said on Tuesday.
Ashok Gehlot govt to urge PM Modi to allow Covid booster dose
Nov 20, 2021, at 01:22 am
Jaipur/UNI: The Rajasthan government is preparing to introduce the third booster dose of Covid-19 to check the spread of coronavirus.
WHO's clearance to Bharat Biotech's Covaxin delayed: Reports
Sep 28, 2021, at 03:12 am
New Delhi/IBNS: The World Health Organization (WHO) has further delayed the emergency use authorisation (EUA) for Covaxin, the COVID vaccine developed in India by pharmaceutical company Bharat Biotech, media reports said.
COVID ‘Shot for All’, not a luxury, but development priority: UNDP
Sep 22, 2021, at 09:28 pm
New York:Top politicians joined award-winning African performers and others on Tuesday, in New York, to take part in a special event organized by the UN Development Programme (UNDP), to discuss how COVID-19 vaccines can be fairly distributed worldwide, as a key priority for development.
Johnson & Johnson's second COVID-19 booster shot is 94 pct effective against moderate-severe disease
Sep 22, 2021, at 12:27 am
Washington: Johnson & Johnson on Tuesday said its COVID-19 second booster vaccine shot is 94 percent effective when administered within two months after applying the first dose in the US.
Moderna's COVID vaccine approved by EU regulator for use on children aged 12-17
Jul 24, 2021, at 04:54 am
The Hague, Netherlands/ IBNS: Moderna's coronavirus vaccine has been approved by the European regulator for use on children aged 12 to 17, making it the second jab to be administered on adolescents in the continent.
US FDA adds warning on Johnson & Johnson COVID-19 vaccine related to rare neurological disorder
Jul 13, 2021, at 02:18 pm
Washington/UNI/Xinhua: The US Food and Drug Administration (FDA) added a new warning on the Johnson & Johnson COVID-19 vaccine, saying the vaccine has been linked to a serious but rare side effect called Guillain-Barre syndrome.
India to accept single-dose vaccine Sputnik Light's trial data from Russia: Dr. Reddy's
Jul 02, 2021, at 04:21 am
New Delhi/IBNS: A government expert panel has provided green signal to Russian-made single-dose Sputnik Light COVID-19 vaccine to submit its phase 3 trial data, the vaccine's India-partner Dr Reddy's said on Thursday.
Novavax may get approval in two months, likely to be costlier than Covishield
Jul 01, 2021, at 02:28 am
New Delhi/IBNS: The Covovax shot developed by US vaccine-maker Novavax may be cleared for use in India between July and September, which would make it the fifth vaccine approved in the South Asian country.
India approves US-made Moderna vaccine for emergency use against COVID-19
Jun 30, 2021, at 06:13 am
New Delhi/IBNS: The Centre on Tuesday cleared the fourth vaccine, the US-made Moderna, for emergency use in India.
Novavax COVID-19 vaccine demonstrates 90 percent overall efficacy
Jun 14, 2021, at 11:13 pm
Gaithersburg, Maryland: American biotechnology company Novavax, Inc on Monday announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100 percent protection against moderate and severe disease, 90.4 percent efficacy overall, and met the primary endpoint in its prevent-19 pivotal Phase 3 trial.
Vaccines' effectiveness on Indian variant of Covid remains uncertain: WHO
May 14, 2021, at 04:44 am
New Delhi/IBNS: The World Health Organization (WHO) has expressed uncertainty about the effectiveness of vaccines on the Indian variant of coronavirus, which it had already claimed to be deadlier and more infectious.
Centre introduces security code in CoWIN app to eliminate data entry errors
May 08, 2021, at 04:59 am
New Delhi/IBNS: To eliminate data entry errors about vaccination status, the CoWIN system will introduce a four-digit security code starting Saturday, the Health Ministry has said.
Kolkata's Peerless Hospital commences Johnson & Johnson vaccine's clinical trial
May 08, 2021, at 03:50 am
Kolkata/IBNS: Kolkata's Peerless Hospital has been selected as the only trial venue in the East for Johnson & Johnson for their single-dose vaccine which is currently being used under emergency authorization.
Russia approves single-dose version of Sputnik Covid vaccine for use
May 07, 2021, at 04:24 am
Moscow/IBNS: Health officials in Russia have approved a single-dose version of its Covid vaccine Sputnik V, reports said on Thursday.
UK to offer AstraZeneca vaccine's alternative to people below 30 yrs over concerns of blood clots
Apr 08, 2021, at 04:27 am
London/IBNS: Amidst concerns over rare blood clot disorders resulting in deaths of people following inoculation, a government committee in the UK has said that those below 30 years of age should be offered an alternative to the AstraZeneca Covid vaccine.
'AstraZeneca safe but can't rule out link to rare clotting disorder': Europe medical regulator
Mar 19, 2021, at 04:52 am
Amsterdam/IBNS: Europe's medical regulator said Thursday declared the AstraZeneca Covid vaccine as "safe and effective".
AstraZeneca Covid vaccine safe, works extremely well: Boris Johnson
Mar 17, 2021, at 02:42 am
New Delhi/IBNS: British Prime Minister Boris Johnson on Tuesday came out in support of AstraZeneca coronavirus vaccine after several European countries temporarily halted the use of the shot, following reports of blood clots in people who received the vaccine from two batches.
Denmark, Norway, Iceland suspend use of AstraZeneca's Covid vaccine over concerns of blood-clot
Mar 12, 2021, at 05:29 am
Copenhagen/IBNS: Several European countries like Denmark, Norway and Iceland Thursday temporarily suspended the use of Oxford-AstraZeneca's Covid-19 vaccine over concerns about patients suffering from post-jab blood clots.
Oxford Vaccine trials resume in UK days after pause over volunteer's illness
Sep 13, 2020, at 02:48 am
London/IBNS: Pharmaceutical giant AstraZeneca on Saturday resumed the trials of Covid-19 vaccine in the United Kingdom after a brief halt following a volunteer's illness, media reports said.
India adds close to 61,000 Covid-19 cases, 848 deaths in 24 hours
Aug 25, 2020, at 05:16 pm
New Delhi/IBNS: India, which has been badly-hit by the Novel Coronavirus pandemic, added close to 61,000 fresh infections on Tuesday.
India sets up committee to oversee Covid-19 vaccine distribution: Report
Aug 08, 2020, at 06:55 pm
New Delhi/IBNS: The Centre has formed an expert committee comprising members from the concerned ministries and institutions to look into all the aspects of Covid-19 vaccine plan as six vaccines are in the phase 3 or combined phase 2 and 3 trials and several countries are in the process of finalising deals with multiple vaccine makers.
Jul 04, 2020, at 01:21 pm
New Delhi/IBNS: India's scientific community has termed the Indian Council of Medical Research (ICMR)'s claim to produce the Covid-19 vaccine by Aug 15 as "risky" and "impossible", a media report said.